<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Analysis of HLA class I and II alleles in sporadic inclusion-body myositis</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Springer Science and Business Media LLC</publisher>
				<availability status="unknown"><p>Copyright Springer Science and Business Media LLC</p>
				</availability>
				<date type="published" when="2003-11-01">2003-11-01</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Johannes</forename><forename type="middle">B</forename><surname>Lampe</surname></persName>
							<email>johannes.lampe@schering.de</email>
						</author>
						<author>
							<persName><forename type="first">Gudrun</forename><surname>Gossrau</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Kempe</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Monika</forename><surname>F�ssel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Katja</forename><surname>Schwurack</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rolf</forename><surname>Schr�der</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sabine</forename><surname>Krause</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ralf</forename><surname>Kohnen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Maggie</forename><forename type="middle">C</forename><surname>Walter</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Heinz</forename><surname>Reichmann</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hanns</forename><surname>Lochm�ller</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Klinik für Neurologie</orgName>
								<orgName type="institution">Technische Universität Dresden Fetscherstrasse 74</orgName>
								<address>
									<postCode>01307</postCode>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">University of Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Institut für Immunologie</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">Universität Bonn Klinik und Poliklinik für Neurologie Bonn</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Friedrich-Baur-Institut and Dept. of Neurology</orgName>
								<orgName type="institution">Ludwig-Maximilians-University</orgName>
								<address>
									<settlement>München</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Clinical Development</orgName>
								<orgName type="institution">CNS Sellerstrasse 31</orgName>
								<address>
									<postCode>13342</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Analysis of HLA class I and II alleles in sporadic inclusion-body myositis</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Journal of Neurology</title>
						<title level="j" type="abbrev">Journal of Neurology</title>
						<idno type="ISSN">0340-5354</idno>
						<idno type="eISSN">1432-1459</idno>
						<imprint>
							<publisher>Springer Science and Business Media LLC</publisher>
							<biblScope unit="volume">250</biblScope>
							<biblScope unit="issue">11</biblScope>
							<biblScope unit="page" from="1313" to="1317"/>
							<date type="published" when="2003-11-01" />
						</imprint>
					</monogr>
					<idno type="MD5">7538DCB6CD11DA9C7C3FF183EF4CD050</idno>
					<idno type="DOI">10.1007/s00415-003-0204-3</idno>
					<note type="submission">Received: 20 August 2002 Received in revised form: 23 May 2003 Accepted: 11 June 2003</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:11+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Sporadic inclusion body myositis (s-IBM) is the most common myopathy in individuals over 50 years of age. S-IBM is diagnosed in patients with muscle weakness affecting both proximal and distal muscles of the arms and legs. Clinical characteristics are early involvement of distal muscles, in particular finger flexors and foot extensors, and asymmetric muscle atrophy predominantly in quadriceps muscles and arm flexors <ref type="bibr" target="#b11">[12]</ref>. Frequently, patients suffer from mild dysphagia <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b12">13]</ref>. A 3:1 male preponderance has been observed <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b34">35]</ref>.</p><p>Histologically, s-IBM is characterised by intracellular amyloid deposits accompanied by CD8-positive mononuclear inflammatory infiltrates. Immunohisto-s Abstract Sporadic inclusion body myositis (s-IBM) is characterised by progressive weakness of proximal and distal limb muscles. Most patients are aged over 50 years at disease onset. Muscle biopsy reveals an inflammatory myopathy and cytoplasmic amyloid deposits. The mononuclear infiltrate is dominated by CD8+ T-cells. Several investigators have described associations between s-IBM and certain HLA antigens and alleles. However, to date neither HLA class I nor II alleles have been analysed in a large series of patients. We typed various HLA class I and II alleles in 47 patients suffering from s-IBM using sequence specific-primer pairs (SSP-PCR). The results were compared with published German controls. Additional Bonferroni adjustment was performed over all allele groups corresponding to serologically defined antigens within one HLA class I or II locus. After Bonferroni adjustment, we found a significant increase in frequency of the following HLA alleles for s-IBM patients when compared with normal controls: A*03 (p = 0.0002), B*08 (p = 0.002), DRB1*03 (p = 0.0000002), and DQB1*05 (p = 0.02). HLA typing may be helpful to distinguish between subgroups of s-IBM patients. Moreover, HLA analysis may aid in identifying patients who might profit from future therapeutic strategies.</p><p>s Key words myositis • inclusion body • autoimmune • prion • Alzheimer • HLA chemically, the deposits contain several proteins also found in neurodegenerative diseases. These proteins include amyloid precursor protein (APP), hyperphosphorylated tau protein, apolipoprotein E (ApoE), alpha1-antichymotrypsin (ACT), presenilin-1, ubiquitin and prion protein (PrP) <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref>. The aetiology of IBM is unknown. In contrast to autosomal-dominant or autosomal-recessive hereditary inclusion-body myopathy (h-IBM) s-IBM displays characteristic inflammatory changes <ref type="bibr" target="#b27">[28]</ref>. In both s-IBM and polymyositis (PM), a cell-mediated immune attack is indicated by the invasion of CD8+ cytotoxic T cells into non-necrotic muscle fibres. Since muscle fibres in both IBM and PM strongly express HLA class I molecules on the cell surface, CD8+ cytotoxic T cells most probably recognise antigenic epitopes bound to HLA class I molecules <ref type="bibr" target="#b21">[22]</ref>. Recently, clonal restriction of invading T-cells has been demonstrated in s-IBM <ref type="bibr" target="#b5">[6]</ref>. Furthermore, studies in transgenic mice indicated that MHC expression on the muscle fibre surface alone might be sufficient to cause an inflammatory muscle disease <ref type="bibr" target="#b30">[31]</ref>. Recently, several investigators described an association between certain HLA alleles and s-IBM. However, most studies solely analysed HLA class II haplotypes <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b31">32]</ref> or small numbers of patients <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b31">32]</ref>. This study describes HLA I and II haplotypes in a series of 47 patients suffering from s-IBM.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and Methods</head><p>Patients included in this study fulfil the clinical and histological (light and electron microscopy) criteria for definite s-IBM <ref type="bibr">[37]</ref>. Patients were investigated at the neurological departments at the universities of Munich and Bonn. Genomic DNA was isolated from peripheral blood leukocytes of 47 patients according to the manufacturer's instructions (GenomeClean Kit, AGS GmbH, Heidelberg, Germany). HLA class I and II specificities were identified using Sequence Specific Primer Technology (SSP)-PCR and sequence specific oligonucleotides (SSO) using commercial test kits: (i) Sequence Specific Primer (BAG, Lich, Germany; Olerup AG, Saltsjöbaden, Sweden) and (ii) Sequence Specific Oligonucleotides (SSO) (Dynal Biotech GmbH, Hamburg, Germany). Both SSO and SSP analyses were performed according to the manufacturer's instructions.</p><p>In summary, we tested 77 allele specificities in HLA-A (47 patients), 205 in HLA-B (46 patients), 66 in HLA-C (45 patients), 128 in HLA-II DR (46 patients), and 31 in HLA-DQ (47 patients). These HLA specificities were referred to the corresponding antigen-groups: 22 in HLA-A, 51 in HLA-B, 16 in HLA-Cw, 15 in HLA-DR, and 5 in HLA-DQ. For the PCR amplification procedure a PE-Thermocycler 2400 (Perkin Elmer, Applied Biosystems, Foster City, California) and a Personal Cycler (Biometra, Göttingen, Germany) were used.</p><p>The results of this analysis were compared with normal controls from the general German population: for HLA-A, HLA-B, HLA-DR, HLA-DQ <ref type="bibr" target="#b28">[29]</ref> and HLA-C <ref type="bibr" target="#b16">[17]</ref>. The differences between allele frequencies in patients and controls were judged using the chi-square test. The exact Fisher test or two-tailed test of the difference was performed if cells were low-filled. Nominal, i. e. uncorrected for multiple tests, p-values are presented. Moreover, Bonferroni-adjusted p-values over all allele groups corresponding to serologically defined antigens within one HLA class I or II locus are presented to avoid an alpha-inflation when chaining statistical tests. P-values are adjusted over all corresponding antigens within one HLA class I or II locus (22 in HLA-A, 51 in HLA-B, 16 in HLA-C; 15 in HLA-DRB; and 5 HLA-DQ). The power of the chi-square tests comes from the large number of controls employed. Therefore, p-values shall be considered as an indicator of non-random frequency distributions of particular alleles in s-IBM. This cautious interpretation is recommended because no a priori expectations of such accumulations had been defined prior to the start of the study.</p><p>The absence of linkage disequilibrium between the HLA-B8 allele and the HLA-DR3 allele was tested in 44 IBM patients by the usual likelihood ratio test using the EH program as described by Terwillinger and Ott <ref type="bibr" target="#b35">[36]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>There was a statistically significant increase in the frequency of the A*03, B*08, DRB1*03, and DQB1*05 alleles both with and without Bonferroni adjustment. In detail (Table <ref type="table">)</ref>, we found A*03 in 29.8 % (28 out of 94 alleles) of all IBM alleles versus 14.1 % in the German general population (p = 0.00001; p adjusted = 0.0002), the B*08 allele in 20,6 % (19/92) vs. 8.6 % (p = 0.00004; p adjusted = 0.002), the DRB1*03 allele in 27.2 % (25/92) vs. 9.7 % (p = 0.00000001; p adjusted = 0.0000002), the DQB1*05 allele in 23.4 % (22/94) vs. 13.1 % (p = 0.003; p adjusted = 0.02). Moreover, there is linkage disequilibrium between DRB1*03 and B*08 in the population represented by the sampled IBM patients. The haplotype DRB1*03 B*08 is more frequent than expected (data not shown).</p><p>The p value indicated statistical significance for additional alleles A*24, B*42, B*67, DRB1*15, and DQB1*03. However, the difference in these alleles did not remain statistically significant when calculating Bonferroni adjusted p-values (for more details see Table <ref type="table">)</ref>. So far we did not identify any statistically significant correlation of HLA alleles with other specific features, such as sex or age at disease onset.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>We identified a statistically significant increase in the frequencies of several HLA class I and II alleles in s-IBM. In contrast to former studies we analysed HLA class I and II alleles in a larger series of histologically and ultrastructurally confirmed s-IBM cases.</p><p>We found a statistically significant increase in the frequency of the A*03, B*08, DRB1*03, and DQB1*05 alleles. Two of these possible antigen/allele associations have not been described in s-IBM before (A3/A*03, DQ5/DQB1*05). Furthermore, we confirm previous findings for other associations (B8/B*08 <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>, DR3/DRB1*03 <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b31">32]</ref>.</p><p>The aetiology of s-IBM is probably heterogeneous, but remains elusive at present. Therefore, we can only speculate about the cause of increased HLA alleles in s-IBM. Several hypotheses are discussed: 1. s-IBM caused by viral infection, 2. s-IBM as an autoimmune disorder, 3. s-IBM caused by other, so far unidentified genes in linkage disequilibrium with HLA alleles. 1. Initially it was speculated that s-IBM may represent a slow virus infection of skeletal muscle <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>. HIV-1 and HTLV-1 infections are sometimes accompanied by a disorder clinically and histologically reminiscent of s-IBM. Retroviruses do not directly infect muscles, but persistent retroviral infections may cause superantigenic stimulation and trigger an endomysial inflammatory response similar to s-IBM <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b33">34]</ref>. Interestingly, an s-IBM like disorder has been described in a patient suffering from poliomyelitis <ref type="bibr" target="#b0">[1]</ref>. However, these cases are rare. Therefore, a common viral aetiology of s-IBM appears unlikely. 2. s-IBM is frequently associated with autoimmune disorders such as diabetes mellitus and diffuse peripheral neuropathy <ref type="bibr" target="#b26">[27]</ref>. Koffman and colleagues described autoantibodies in 44 of 99 s-IBM patients <ref type="bibr" target="#b22">[23]</ref>. In s-IBM, muscle fibres are invaded by T cells. Moreover, these T cells show restricted usage of the variable T cell receptor alpha/beta genes, suggesting that antigen stimulated T cells may play an important role in the pathogenesis of s-IBM <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b25">26]</ref>. Putative antigens include autoantigens <ref type="bibr" target="#b20">[21]</ref> and viral agents. 3. Kok et al. suggested the following explanation to elucidate the role of HLA class II alleles in s-IBM <ref type="bibr" target="#b24">[25]</ref>:</p><p>The frequency of alleles at a given chromosomal locus is usually not influenced by the frequency of alleles at another, remote locus. Nevertheless, some HLA class alleles are inherited together more often than expected <ref type="bibr" target="#b14">[15]</ref>. For instance, there is linkage disequilibrium between HLA-DR3 and HLA-B8 in the population represented by the sampled IBM patients <ref type="bibr" target="#b29">[30]</ref>.</p><p>Several genes have been located in the central region of the MHC locus, including the tumour necrosis factor (TNF) alpha and beta gene <ref type="bibr" target="#b6">[7]</ref>, the complement factors 2 and 4 genes, the factor B gene <ref type="bibr" target="#b15">[16]</ref>, as well as three heat shock protein-70 (HSP70) genes <ref type="bibr" target="#b32">[33]</ref>. Additionally, certain HSP70-1 alleles are in linkage disequilibrium with HLA markers <ref type="bibr" target="#b7">[8]</ref> that may be involved in the pathogenesis of neurodegenerative disorders.</p><p>Recently, an increased expression of the chaperone αB-crystalline has been demonstrated in s-IBM, indicating increased stress of histologically normal muscle fibres <ref type="bibr" target="#b4">[5]</ref>. Furthermore, MHC overexpression on the muscle fibre surface of transgenic mice caused an inflammatory muscle disease <ref type="bibr" target="#b30">[31]</ref>. This is further evidence for the importance of HLA molecules in the pathogenesis of s-IBM.</p><p>As for the putative aetiology, response to treatment is heterogeneous in s-IBM. For example, prednisone is effective in some, but fails to prevent disease progression in most s-IBM patients <ref type="bibr" target="#b26">[27]</ref>. Controlled clinical trials have indicated that intravenous immunoglobulin therapy may be ineffective or only marginally effective in s-IBM <ref type="bibr" target="#b13">[14]</ref>). However, some patients clearly profit from this treatment <ref type="bibr" target="#b36">[38]</ref>. Unfortunately, none of the known clinical or laboratory parameters is helpful in predicting response to immunomodulatory therapy in s-IBM. Therefore, therapy is often given on a trial-and-error basis. HLA typing might be used to subgroup s-IBM patients, which could help to identify patients who could be successfully treated with immunomodulatory drugs. Furthermore, costly and inefficient treatment modalities could be avoided in the remaining patients.   </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>1</head><label></label><figDesc>compared with normal controls from the general German population: for HLA-A, HLA-B, HLA-DR a representative population of N = 14835 subjects (corresponding to 29670 alleles) was used; for HLA-DQ another representative reference population consisting of N = 6350 subjects (12700 alleles) was used ( [28]. 2 p-values are adjusted over all corresponding antigens within one HLA class I or II locus (22 in HLA-A, 51 in HLA-B, 16 in HLA-C; 15 in HLA-DRB; and 5 HLA-DQ).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>s</head><label></label><figDesc>Acknowledgements This work was supported by a grant from the Deutsche Forschungsgemeinschaft to JBL and HR (La 925/4-1), and</figDesc><table><row><cell>HLA allele</cell><cell>Allele frequency</cell><cell>Allele frequency</cell><cell>p-value</cell><cell>Bonferroni-</cell></row><row><cell>(corresponding</cell><cell>in s-IBM patients</cell><cell>in normal controls 1</cell><cell></cell><cell>adjusted</cell></row><row><cell>antigen)</cell><cell></cell><cell></cell><cell></cell><cell>p-value 2</cell></row><row><cell>A*03 (A3)</cell><cell>28/94 (29.79 %)</cell><cell>4170/29670 (14.05 %)</cell><cell>0.00001</cell><cell>0.0002</cell></row><row><cell>A*24 (A24 (9))</cell><cell>2/94 (2.13 %)</cell><cell>2720/29670 (9.17 %)</cell><cell>0.01</cell><cell>n.s.</cell></row><row><cell>B*08 (B8)</cell><cell>19/92 (20.65 %)</cell><cell>2562/29670 (8.63 %)</cell><cell>0.00004</cell><cell>0.002</cell></row><row><cell>B*42 (B42)</cell><cell>1/92 (1.09 %)</cell><cell>6/29670 (0.02 %)</cell><cell>F: 0.02</cell><cell>n.s.</cell></row><row><cell>B*67 (B67)</cell><cell>1/92 (1.09 %)</cell><cell>3/29670 (0.01 %)</cell><cell>F: 0.01</cell><cell>n.s.</cell></row><row><cell>DRB1*03 (DR3)</cell><cell>25/92 (27.17 %)</cell><cell>2881/29670 (9.71 %)</cell><cell>0.00000001</cell><cell>0.0000002</cell></row><row><cell>DRB1*15 (DR15)</cell><cell>4/92 (4.35 %)</cell><cell>3461/29670 (11.66 %)</cell><cell>0.03</cell><cell>n.s.</cell></row><row><cell>DQB1*03 (DQ3)</cell><cell>20/94 (21.28 %)</cell><cell>3930/12700 (30.940 %)</cell><cell>0.05</cell><cell>n.s.</cell></row><row><cell>DQB1*05 (DQ5)</cell><cell>22/94 (23.40 %)</cell><cell>1664/12700 (13.10 %)</cell><cell>0.003</cell><cell>0.02</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table</head><label></label><figDesc>All HLA class I and II alleles that are more frequently found in s-IBM patients than in normal controls are listed (chi-square test or two-tailed Fisher exact test (F), significant at global alpha = 0.05); n. s. not significant</figDesc><table /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>by fellowships from Grifols Deutschland GmbH, (Langen, Germany) and The Myositis Association (Harrisonburg, U. S. A.) to SK. We are grateful for the scientific advice of Prof. Schneider, Institut für Med.</p><p>Biometrie und Epidemiologie Philipps-Universitaet Marburg, regarding LD analysis.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Inclusion body myositis in post-poliomyelitis muscular atrophy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Abarbanel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lichtenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zirkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Louzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Osimani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Farkash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Herishanu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurol Scand</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="81" to="84" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="486" to="496" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Prion protein is abnormally accumulated in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leclerc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="25" to="28" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wisniewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="889" to="895" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">AlphaBcrystallin immunolocalization yields new insights into inclusion body myositis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Banwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1033" to="1041" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">T-cell heterogeneity in muscle lesions of inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Behrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="86" to="91" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Katzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Alicot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Koller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Geraghty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Orr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Strominger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Spies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="8535" to="8539" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Gametic association of HSP70-1 promoter region alleles and their inclusion in extended HLA haplotypes</title>
		<author>
			<persName><forename type="first">I</forename><surname>Cascino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D'</forename><surname>Alfonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cappello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Giordano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pugliese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Awdeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Alper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Richiardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tissue Antigens</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="62" to="66" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. A possible chronic persistent muscle infection by mumps virus</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cleve Clin Q</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="583" to="589" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Baillieres Clin Neurol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="557" to="577" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Inclusion body myositis in HIV-1 and HTLV-1 infected patients</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Cupler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Monzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Semino-Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1887" to="1893" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>Pt 6</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="70S" to="75S" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Dysphagia as a frequent manifestation in patients with inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Sonies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lopez-Devine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Sapper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page">A116</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>Suppl.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Koffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fujii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Spector</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cupler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="323" to="327" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dausset</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Legrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Lepage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Contu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marcelli-Barge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wildloecher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Benajam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Meo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Degos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tissue Antigens</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="297" to="307" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Dunham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sargent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Trowsdale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Campbell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="7237" to="7241" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title level="m" type="main">Caucasian German Normal</title>
		<author>
			<persName><forename type="first">H</forename><surname>Eichler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Woelpel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Goldmann</surname></persName>
		</author>
		<editor>HLA 1998 DW Gjestson, Terasaki PI</editor>
		<imprint>
			<date type="published" when="1997">1997</date>
			<publisher>American Society for Histocompatibility and Immunogenetics</publisher>
			<biblScope unit="page" from="150" to="151" />
			<pubPlace>Larosa, Kansas, USA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Mosavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="185" to="189" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Immunogenetics of inflammatory myopathies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Baillieres Clin Neurol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="579" to="597" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">HLA associations with inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ollier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="40" to="45" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="498" to="507" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Cellular mechanisms in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Baillieres Clin Neurol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="617" to="635" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Koffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rugiero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="115" to="117" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Koffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Simonis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stroncek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="139" to="142" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Croager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Witt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kiers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="508" to="516" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2659" to="2663" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. Observations in 40 patients</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Lotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Litchy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="727" to="747" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note>Pt 3</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mikol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<editor>Myology AG Engel, Franzini-Armstrong C</editor>
		<imprint>
			<date type="published" when="1994">1994</date>
			<publisher>McGraw-Hill</publisher>
			<biblScope unit="page" from="1384" to="1398" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">German Normal</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Goldmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wegener</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">American Society for Histocompatibility and Immunogenetics 1997</title>
				<editor>
			<persName><surname>Hla 1998 Dw Gjestson</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Terasaki</surname></persName>
		</editor>
		<meeting><address><addrLine>Larosa, Kansas, USA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1997">1997</date>
			<biblScope unit="page" from="154" to="157" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Gene and haplotype frequencies for the loci HLA-A, HLA-B, and HLA-DR based on over 13,000 German blood donors</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ehninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Goldmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Immunol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="137" to="151" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nagaraju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Raben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Loeffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Rochon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Danning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bahtiyar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Craft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hooft</forename><surname>Van Huijsduijnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="9209" to="9214" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Rider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Gurley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Garcia</forename><surname>De La Torre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kalovidouris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Hennekam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Baumbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Neville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Klingman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gibbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weisman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Targoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="710" to="719" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Human major histocompatibility complex contains genes for the major heat shock protein HSP70</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sargent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dunham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Trowsdale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Campbell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1968" to="1972" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: atypical clinical presentations</title>
		<author>
			<persName><forename type="first">I</forename><surname>Schlesinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Soffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lossos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Meiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Neurol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="89" to="93" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: new concepts</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Sekul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="256" to="263" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Diagnostic criteria of inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Terwilliger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Vershuuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bgm</forename><surname>Van Engelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Der Hoeven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hoogendijk</surname></persName>
		</author>
		<editor>. A Emery</editor>
		<imprint>
			<date type="published" when="1994">1994. 1997</date>
			<publisher>Royal Society of Medicine Press</publisher>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="81" to="85" />
			<pubPlace>Baltimore; London</pubPlace>
		</imprint>
	</monogr>
	<note>Handbook for Human Genetic Linkage</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lochmuller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Toepfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schlotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reilich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Muller-Felber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pongratz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol</title>
		<imprint>
			<biblScope unit="volume">247</biblScope>
			<biblScope unit="page" from="22" to="28" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
